StockData
Ensysce Biosciences, Inc. logo

Ensysce Biosciences, Inc. (ENSC) stock

ENSCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.38−0.03 (-6.28%)

Close on Nov 17, 2026Market cap $7.47MP/E –Yield –

Ensysce Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Ensysce Biosciences's profit margin for the twelve months ending Sep 30, 2021 was -663.5%. For fiscal 2020 it was 109.7%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020109.7%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2021Sep 30, 2021-1429.3%−1619.1
Q2 FY2021Jun 30, 2021-210.5%−171.9
Q1 FY2021Mar 31, 2021-683.1%–
Q4 FY2020Dec 31, 20201072.8%–
Q3 FY2020Sep 30, 2020189.8%–
Q2 FY2020Jun 30, 2020-38.6%–

More Ensysce Biosciences figures

See a number that looks wrong?